Henlius Announces Positive Phase I/II Results For Ophthalmic Bevacizumab Biosimilar
HLX04-O Could Be One Of The First Bevacizumab Products Formally Indicated For Ophthalmology
Bevacizumab is usually used off-label to treat ocular conditions • Source: Shutterstock 
